Chemsrc Level:Unverified
Tel:022-29465809
Address:Zhongrui Pharmaceutical Industry, Chengguan Town, Wuqing District, Tianjin
Area:
China Contact:wang
Contact Phone #:15822926311
Email:3528213841@qq.com
Website:http:// Annual Trade Volume: Foreign Trade % of Sales: Major partners:
The Introduction of Tianjin Zhongrui Pharmaceutical Co., Ltd
Tianjin Zhongrui Pharmaceutical Co., Ltd is a professional productive enterprise dedicated to active pharmaceutical ingredients and intermediates, established in 2004, with total registered capital of CNY26million. The company’s main products include Niacin, Niacinamide, Inositol Nicotinate, Terazosin HCl, Clopidogrel Hydrogen Sulfate, Dopamine HCL, Febuxostat. Tianjin Zhongrui serves as an integrated pharmaceutical manufacturer, owning advanced production equipments, “GMP” workshops, and various sophisticated testing instruments. Most of the company leadership team members are professional and technical personnel with rich experience in pharmaceutical, went to college or gaining further education. The site covers total area of 21000m2, , of which production workshops 1656m2, QC laboratory 360m2. Production line of each API is equipped with specially designed equipments and independent air conditioning system. Our quality control capability is qualified to the production scale. All products passed the GMP certification. Our facility conditions conforms to the requirements of the technology, production safety, environmental protection. Internal research institute is armed with advanced R&D equipments and pilot plant. Tianjin Zhongrui relies on strong technical force, high-quality team, perfect quality assurance system to elaborately creats himself a high-tech enterprise, thereof has achieved rapid development on basis of science and technology. Tianjin Zhongrui was identified as high-tech enterprise at 2009. And been recertificated at 2012. The Nicotinamide manufacture process has been brought into Tianjin Science and Technology Committee science innovation projects. The Strontium Ranelate manufacture got support from “Technician serve companies” hold by National Technology Administration. Zhongrui invested 3 million for research. In order to introduce advanced production technology of new drugs and pursue better and faster development, Tianjin Zhongrui cooperated with a technology- based private institute from Beijing in 2009, which is specialized in new drug research and development. This institute invested six new drug research achievements and CNY 6 million, which injected a huge fresh vitality of science and technology to Tianjin Zhongrui.
Only products of verified suppliers can be displayed here. Please visit service member page for details.
Member service